Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Science

Volumn 298, Issue 5594, 2002, Pages 850-854

  Dudley, Mark E ^a   Wunderlich, John R ^a   Robbins, Paul F ^a   Yang, James C ^a   Hwu, Patrick ^a   Schwartzentruber, Douglas J ^a   Topalian, Suzanne L ^a   Sherry, Richard ^a   Restifo, Nicholas P ^a   Hubicki, Amy M ^a   Robinson, Michael R ^a   Raffeld, Mark ^a   Duray, Paul ^a   Seipp, Claudia A ^a   Rogers Freezer, Linda ^a   Morton, Kathleen E ^a   Mavroukakis, Sharon A ^a   White, Donald E ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; DISEASE CONTROL; PATIENT MONITORING; TUMORS;

ANTI TUMOR LYMPHOCYTES;

IMMUNOLOGY;

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CANCER; IMMUNE RESPONSE;

ADULT; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CANCER CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL TRANSFER; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, NEOPLASM; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTOKINES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0037174674     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1076514     Document Type: Article

References (29)

1. S. A. Rosenberg et al., Nature Med. 4, 321 (1998).
2. S. A, Rosenberg et al., J. Natl. Cancer Inst. 86, 1159 (1994).
3. C. Yee et al., J. Exp. Med. 192, 1637 (2000).
4. M. E. Dudley et al., J. Immunother. 24, 363 (2001).
5. M. E. Dudley et al., J. Immunother. 25, 243 (2002).
6. J. R. Berenson, A. B. Einstein Jr., A. Fefer, J. Immunol. 115, 234 (1975).
7. T. J. Ebertein, M. Rosenstein, S. A. Rosenberg, J. Exp. Med. 156, 385 (1982).
8. R. J. North, J. Exp. Med. 155, 1063 (1982).
9. S. A. Rosenberg, P. Spiess, R. Lafreniere, Science 233, 1318 (1986).
10. S. A. Rosenberg, J. C. Yang, D. E. White, S. M. Steinberg, Ann. Surg. 228, 307 (1998).
11. Materials and methods are available as supporting material on Science Online.
12. B. D. Cheson, J. Clin. Oncol. 13, 2431 (1995).
13. Y. Kawakami et al., Proc. Natl. Acad. Sci. U.S.A. 91, 3515 (1994).
14. M. E. Dudley et al., unpublished observations.
15. U. Boehm, T. Klamp, M. Groot, J. C. Howard, Annu. Rev. Immunol. 15, 749 (1997).
16. R. J. O'Reilly et al., Important Adv. Oncol. 1996, 149 (1996).
17. C. M. Rooney et al., Blood 92, 1549 (1998).
18. S. R. Riddell et al., Science 257, 238 (1992).
19. E. A. Walter et al., N. Engl. J. Med. 333, 1038 (1995).
20. R. T. Mitsuyasu et al., Blood 96, 785 (2000).
21. R. E. Walker et al., Blood 96, 467 (2000).
22. M. F. Callan et al., J. Clin. Invest 106, 1251 (2000).
23. A. D. Hislop, N. E. Annels, N. H. Gudgeon, A. M. Leese, A. B. Rickinson, J. Exp. Med. 195, 893 (2002).
24. S. A. Rosenberg et al., N. Engl. J. Med. 323, 570 (1990).
25. M. Matloubian, R. J. Concepcion, R. Ahmed, J. Virol. 68, 8056 (1994).
26. S. C. Jameson, Nature Rev. Immunol. 2, 547 (2002).
27. R. Childs et al., N. Engl. J. Med. 343, 750 (2000).
28. S. R. Riddell, P. D. Greenberg, J. Immunol. Methods 128, 189 (1990).
29. The authors thank the clinical fellows and nursing staffs on the 2E and 2J wards of the Clinical Center, NIH, for excellent patient care; the technicians in the Surgery Branch TIL lab, NCI, for generation of the T cell cultures; C. Yee and S. Riddell for help in the early stages of this project; and M. Bishop and J. Gea-Banacloche for advice on patient care related to infectious disease.